These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 14694852)

  • 1. Blood transfusion-induced immunomodulation--is storage time important?
    Mynster T
    Dan Med Bull; 2003 Nov; 50(4):368-84. PubMed ID: 14694852
    [No Abstract]   [Full Text] [Related]  

  • 2. [Transfusions of older blood products may pose a risk. Knowledge of storage and transfusion-related injuries is unclear].
    Tornqvist F; Ivarsson KE; Fransson MD; Schmidt-Melbye AC; Algotsson L; Schött U
    Lakartidningen; 2012 Apr 4-10; 109(14-15):754-7. PubMed ID: 22611880
    [No Abstract]   [Full Text] [Related]  

  • 3. The immunomodulation effect of allogenic blood transfusion in colorectal cancer--a new approach.
    Sabalić S; Kovacević D; Glavić Z; Buković D; Despot A; Fajdić J; Lukac J; Seso I
    Coll Antropol; 2006 Dec; 30(4):885-93. PubMed ID: 17243565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Peroperative transfusion and colorectal cancer. Cooperative Study Group for Transfusion and Cancer of the Colon in Mallorca].
    Sangre (Barc); 1989 Aug; 34(4):292-6. PubMed ID: 2672383
    [No Abstract]   [Full Text] [Related]  

  • 5. ACD-adenine infusions in humans.
    Soulier JP
    Transfusion; 1967; 7(6):461. PubMed ID: 6080939
    [No Abstract]   [Full Text] [Related]  

  • 6. Transfusion medicine faces time of major 'challenges and changes'.
    Skolnick AA
    JAMA; 1992 Aug; 268(6):697. PubMed ID: 1640563
    [No Abstract]   [Full Text] [Related]  

  • 7. [Standards in the surgery of colorectal carcinoma].
    Farthmann EH; Kirchner R; Keller H
    Dtsch Med Wochenschr; 1989 Feb; 114(7):266-7. PubMed ID: 2917489
    [No Abstract]   [Full Text] [Related]  

  • 8. Comments on "Release of immune modulation factors from platelet concentrates during storage after photochemical pathogen inactivation treatment".
    Apelseth T; Hervig T
    Transfusion; 2009 Mar; 49(3):603-4; author reply 604-5. PubMed ID: 19243549
    [No Abstract]   [Full Text] [Related]  

  • 9. Leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer.
    Jensen LS
    Lancet; 1994 Nov; 344(8934):1429; author reply 1430-1. PubMed ID: 7848458
    [No Abstract]   [Full Text] [Related]  

  • 10. [Perioperative transfusion in colorectal surgery].
    Benoist S
    Ann Chir; 2005; 130(6-7):365-73. PubMed ID: 16023458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of storage time of red blood cells on microcirculation and tissue oxygenation in critically ill patients.
    Frenzel T; Westphal-Varghese B; Westphal M
    Curr Opin Anaesthesiol; 2009 Apr; 22(2):275-80. PubMed ID: 19390254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of massive transfusions of preserved blood with different storage periods on liver function].
    Iakobson MM; Kniazeva GD; Guseĭnov ChS; Rakhmaeva VA
    Khirurgiia (Mosk); 1973 Mar; 49(3):74-9. PubMed ID: 4754931
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug allergy shock in the transfusion of blood stabilized with a solution of TsOLIPK 76].
    Kondurtsev VA
    Probl Gematol Pereliv Krovi; 1979 Mar; 24(3):45-6. PubMed ID: 432227
    [No Abstract]   [Full Text] [Related]  

  • 14. Transfusion-related immunomodulation due to peripheral blood dendritic cells expressing the CD200 tolerance signaling molecule and alloantigen.
    Clark DA; Gorczynski RM; Blajchman MA
    Transfusion; 2008 May; 48(5):814-21. PubMed ID: 18298594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The silent risks of blood transfusion.
    Rawn J
    Curr Opin Anaesthesiol; 2008 Oct; 21(5):664-8. PubMed ID: 18784496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of allogeneic transfusions.
    Heiss MM
    Br J Anaesth; 1998 Dec; 81 Suppl 1():16-9. PubMed ID: 10318983
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical consequences TRIM (Transfusion related immunomodulation)].
    Průcha M
    Vnitr Lek; 2006 Nov; 52(11):1012-3. PubMed ID: 17165518
    [No Abstract]   [Full Text] [Related]  

  • 18. [Microclots in preserved blood].
    Kartashevskiĭ NG; Rumiantsev VV
    Probl Gematol Pereliv Krovi; 1968 May; 13(5):6-9. PubMed ID: 5735574
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood transfusion in cancer surgery: a consensus statement.
    Houbiers JG; Busch OR; Van de Watering LM; Marquet RL; Brand A; Jeekel H; Van de Velde CJ
    Eur J Surg; 1995 May; 161(5):307-14. PubMed ID: 7662772
    [No Abstract]   [Full Text] [Related]  

  • 20. Rationale and strategy for utilization of available blood in transfusion practice--an overview.
    Khurana SK; Thergaonkar A; Dhupia JS; Verma SK; Talib VH
    Indian J Pathol Microbiol; 1996 Oct; 39(4):343-54. PubMed ID: 9009494
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.